Skip to content

Evaluation of general body and brain functions in children, adolescents and young adults undergoing electroconvulsive therapy

Evaluation of systemic hemodynamics and cerebral functions in children, adolescents and young adults undergoing modified electroconvulsive therapy - A prospective observational study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036487
Enrollment
48
Registered
2021-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F939- Childhood emotional disorder, unspecified

Interventions

None listed

Sponsors

National Institute of Mental Health and Neurosciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: � Children and adolescents (aged less than 18 years) and young adults of age 18 to 24 years (control group) undergoing modified ECT as part of the management of their Axis I Psychiatric diagnosis � Written informed consent from parents and informed assent from children/adolescents � Written informed consent from the adult participants/the relative who is giving consent for ECT

Exclusion criteria

Exclusion criteria: � Patients with intracranial pathology, � Patients with baseline SpO2 of � Baseline HR of � Pre-existing cardiac diseases and cardiac arrhythmias

Design outcomes

Primary

MeasureTime frame
�To evaluate the effects of ECT on systemic hemodynamics, cerebral oxygenation, and the cerebral electrical activity using PSI in pediatric patients undergoing modified ECT �To evaluate autonomic dysfunction due to ECT Timepoint: Heart rate, SpO2, NIBP will be recorded every 1 minute PSI and rSO2 values will be recorded every 30 seconds until 5 minutes after the ECT stimulus, and at 10 min and 15 min following ECT. The autonomic system using ANSiscope will be monitored prior to anesthetic induction and immediately after ECT.

Secondary

MeasureTime frame
To compare all the above parameters with a group of controls; patients between the age of 18- 24 years (matched for gender), who are also undergoing ECTTimepoint: Comparison will be made in the above mentioned respective time points.;To determine the incidence of systemic and airway related complications Timepoint: During management and observation of the case till discharge to the ward.;To evaluate the effect of ECT on clinical outcome using the CGI and C-GAS assessmentTimepoint: Baseline, after the completion of ECT sessions, one month after during the follow up;To evaluate the seizure duration (both EEG and motor seizure)Timepoint: During the induction of modiifed ECT.

Countries

India

Contacts

Public ContactRajeeb Kumar Mishra

National Institute of Mental Health and Neurosciences

litu86@gmail.com9968961339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026